Industry

Top highlights this week include: Colon cancer, medical conspiracy theories, Minnesota Lynx jerseys, osteoporosis and proton beam therapy.

By Kelley Luedke • March 21, 2014

Top highlights this week include: Alzheimer’s, insurance under health care law, stem cell transplants, Destination Medical Center jobs and shortage of cancer doctors.

By Kelley Luedke • March 14, 2014

The Week In Review provides an overview of the past week’s top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events. Top highlights this week include: heath insurance at work, 30,000 year old virus revived, Franciscan legacy, Yampa Valley Medical Center and Mayo Clinic collaboration and H.I.V. in babies.

By Kelley Luedke • March 7, 2014

Friedreich ataxia (FRDA) has been historically diagnosed using a DNA-based molecular test to detect the presence of the trinucleotide (GAA) repeat expansion in intron 1 of the FXN gene. While genetic testing is available for diagnosis of FRDA, measurement of frataxin protein concentration by immunoassay is faster, less costly, and may have greater utility to detect disease. The frataxin immunoassay developed at Mayo Clinic provides a simple, accurate, and reproducible method to measure frataxin protein concentrations.

By Kelley Luedke • March 1, 2014

The Week In Review provides an overview of the past week’s top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events. Top highlights this week include: 3-D printing technology, flu hitting young people, genetic alterations, iPads and patients, and cell morphing.

By Kelley Luedke • February 28, 2014

The Week In Review provides an overview of the past week’s top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events. Top highlights this week include doctor ratings, IVF procedures, modern age healthcare, exclusive interview with Dr. Noseworthy and Rochester featured on David Letterman Small Town News.

By Kelley Luedke • February 21, 2014

The Week In Review provides an overview of the past week’s top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events. Top highlights this week include breast cancer, HPV vaccine, WellStar Health System collaboration, prostate cancer and UnitedHealth-Mayo venture Optum Labs.

By Kelley Luedke • February 14, 2014

The Week In Review provides an overview of the past week’s top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events. Top highlights this week include anti-smoking campaign, cancer tidal wave, Minnesota Timberwolves and Mayo Clinic partnership, Dr. John Noseworthy on health care and Destination Medical Center budget.

By Kelley Luedke • February 6, 2014

The Week In Review provides an overview of the past week’s top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events. Top highlights this week include patient health care costs, genetic testing, health insurance updates, Muppets’ mini-makeover and pertussis.

By Kelley Luedke • January 24, 2014

The Week In Review provides an overview of the past week’s top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events. Top highlights this week include stem cell research, multiple sclerosis, modernizing healthcare, Mayo Clinic’s 150th year anniversary and breast cancer risks.

By Kelley Luedke • January 23, 2014

The Week In Review provides an overview of the past week’s top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events. Top highlights this week include experimental gene therapy, health care law, the flu, Mayo Clinic Destination Medical Center and a new laboratory test.

By Kelley Luedke • January 16, 2014

Currently, several United States Food and Drug Administration (FDA)-approved specific inhibitors of certain molecular targets are effective for treating patients with non-small cell lung cancer (NSCLC). Patients should undergo EGFR and ALK testing on their tumors using FFPE tissues.

By Kelley Luedke • January 2, 2014

With Thanksgiving right around the corner, turkey is on everyone’s mind. To make this time of year a fun and safe one, the Centers for Disease Control and Prevention (CDC) has compiled a few Turkey Basics when it comes to preparing food for the holidays.

By Kelley Luedke • November 26, 2013